ArticleBlood advances2025

N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTP.

Tim Postmus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.